Quantcast

Latest Proteins Stories

2014-07-11 23:02:37

The proteomics market showcases a high growth potential, owing to the growing awareness about personalized medicine and the resultant increase in the use of proteomic technologies-based advancement in the pharmaceutical industry. http://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html (PRWEB) July 11, 2014 The “Proteomics Market by Technology (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray...

2014-07-08 23:12:55

Fit On Studios gives the thumbs up to EnergyFirst’s line of all-natural supplements for its indoor cycling, TRX and Barre clientele. Manhattan Beach, CA (PRWEB) July 08, 2014 Fit On Studios specializes in indoor cycling (spinning), TRX and Barre. As a growing and thriving studio, Fit On owners wanted to find the best nutritional products to offer their clients for pre and post workouts. They researched the marketplace, which is saturated with products loaded with chemicals, shaky...

2014-07-08 23:09:06

GIA announces the release of a comprehensive global report on Whey Protein Ingredients markets. Global market for Whey Protein Ingredients is projected to cross 1.8 billion pounds by 2020, driven by increasing focus on health maintenance and the ensuing rise in demand for whey protein supplements. San Jose, California (PRWEB) July 08, 2014 Follow us on LinkedIn - Proteins are considered vital for human beings, given their significance in promoting wellness and health. Among protein...

2014-07-07 16:24:14

NEW YORK, July 7, 2014 /PRNewswire/ -- Mariel Therapeutics, Inc. today announced that it has entered into a definitive agreement to acquire Stryker Corporation's (NYSE: SYK) Bone Morphogenetic Protein-7 (BMP-7) assets for the potential treatment of osteoarthritis (OA), chronic kidney disease (CKD) and other organ fibrosis conditions, lupus, and obesity. Under the terms of the agreement, Mariel acquired the rights to over 450 issued and pending patents, Stryker's BMP-7-related clinical...

2014-07-07 10:11:17

McGill University Scientists at the Montreal Neurological Institute and Hospital, McGill University and McGill University Health Centre have shown that a member of the protein family known as SUMO (small ubiquitin-like modifier) is a key to why tumour cells multiply uncontrollably, especially in the case of glioblastoma. The SUMO family proteins modify other proteins and the SUMOylation of proteins are critical for many cellular processes. Identifying SUMO’s role in the cancer cell...

2014-07-02 10:16:43

APS A diagnosis of pancreatic cancer—the fourth most common cause of cancer death in the U.S.—can be devastating. Due in part to aggressive cell replication and tumor growth, pancreatic cancer progresses quickly and has a low five-year survival rate (less than 5 percent). GRP78, a protein that protects cells from dying, is more abundant in cancer cells and tissue than in normal organs and is thought to play a role in helping pancreatic cancer cells survive and thrive. Researchers at...

2014-06-30 23:23:05

Visiopharm's new Virtual Double Staining (VDS) Ki67 module for breast is a novel, patented and now CE-marked diagnostic APP intended for automated tumor/stroma separation and computation of the Ki67 labelling index for the identified tumor cells. Hoersholm, Denmark (PRWEB) June 30, 2014 The Virtual Double Staining (VDS) Ki67 module for breast is a novel, patented and now CE-marked diagnostic APP intended for automated tumor/stroma separation and computation of the Ki67 labelling index...

2014-06-30 12:31:45

NEW YORK, June 30, 2014 /PRNewswire/ -- Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease (AD) and related neurodegenerative disorders, announced today the company will be presenting its lead drug development program during both the 9(th) Federation of European Neuroscience Societies (FENS) Forum of Neuroscience to be held July 5 - 9, 2014, in Milan, Italy and at the Alzheimer's Association International...

2014-06-28 14:30:53

Southwestern Medical Center A drug that blocks the action of the enzyme Cdk5 could substantially reduce brain damage if administered shortly after a stroke, UT Southwestern Medical Center research suggests. The findings, reported in the June 11 issue of the Journal of Neuroscience, determined in rodent models that aberrant Cdk5 activity causes nerve cell death during stroke. “If you inhibit Cdk5, then the vast majority of brain tissue stays alive without oxygen for up to one...

2014-06-27 18:45:05

University of Minnesota Academic Health Center New structures discovered within cilia show a relationship between certain proteins and juvenile myoclonic epilepsy. The discovery, made at the University of Minnesota, was named paper of the week in the Journal of Biological Chemistry, and sheds new light on the microstructure of cilia. Cilia are microscopic, hair-like structures occurring in large numbers on the surface of some of the body's cells and are involved in movement and...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'